Actinium Pharmaceuticals, Inc. (ATNM) Net Cash Provided by (Used in) Financing Activities USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Actinium Pharmaceuticals, Inc. quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2024.
  • Actinium Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $14.8M, a 1818% increase year-over-year.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $14.8M +$14M +1818% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $14.9M -$8.24M -35.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q1 2023 $770K +$792K Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $23.1M -$12.1M -34.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q1 2022 -$22K -$14.4M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $35.2M -$41M -53.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q1 2021 $14.3M +$11.8M +464% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $76.2M +$59.1M +345% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q1 2020 $2.54M +$750K +41.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $17.1M +$133K +0.78% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q1 2019 $1.79M -$13.1M -87.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 $17M -$1.83M -9.75% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-08
Q1 2018 $14.9M +$13M +676% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $18.8M +$3.04M +19.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q1 2017 $1.92M +$519K +37.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $15.8M -$21.8M -58% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q1 2016 $1.4M -$17M -92.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $37.5M +$21.8M +139% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q1 2015 $18.4M +$15.6M +548% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $15.7M +$9.48M +152% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q1 2014 $2.84M +$2.9M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $6.22M +$1.09M +21.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q1 2013 -$65.3K -$725K -110% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $5.13M -$895K -14.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q1 2012 $660K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $4.12K* Oct 1, 2011 Dec 31, 2011 10-Q 2012-04-23
Q4 2011 $6.03M +$6.04M Jan 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q4 2010 -$9.81K* Jan 1, 2010 Dec 31, 2010 10-K 2012-04-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.